Multiplicity: Mixed feelings [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2012-11-30 16:52 (4959 d 10:28 ago) – Posting: # 9647
Views: 24,894

Hi Anders!
  1. Yes. On the 16th of November there was an “EMA workshop on multiplicity issues in clinical trials”. Personally I perform an α-adjustment if I study more than one strength (e.g., in line extensions).
  2. :-D
  3. Doesn’t make sense, IMHO. We have two independent patient populations who’s α is 5%. They don’t overlap (leaving the few Memphis’ rednecks dropping into a pharmacy in Clermont-Ferrand aside).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
317 visitors (0 registered, 317 guests [including 28 identified bots]).
Forum time: 04:21 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5